Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-15

FDA Approved: LACOSAMIDE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for lacosamide from Aurobindo Pharma Limited, enabling the marketing of a generic lacosamide product. This is a suppleme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lacosamide (Lacosamide)

Snippet

SUPPL AP for LACOSAMIDE (LACOSAMIDE)